Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Public Employees Retirement Association of Colorado

Public Employees Retirement Association of Colorado cut its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 460,531 shares of the medical research company’s stock after selling 741 shares during the period. Thermo Fisher Scientific comprises approximately 0.8% of Public Employees Retirement Association of Colorado’s investment portfolio, making the stock its 27th biggest holding. Public Employees Retirement Association of Colorado owned approximately 0.11% of Thermo Fisher Scientific worth $134,139,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Ipswich Investment Management Co. Inc. increased its position in shares of Thermo Fisher Scientific by 0.5% in the 2nd quarter. Ipswich Investment Management Co. Inc. now owns 7,773 shares of the medical research company’s stock valued at $2,283,000 after purchasing an additional 35 shares during the last quarter. Karp Capital Management Corp increased its stake in shares of Thermo Fisher Scientific by 0.7% in the third quarter. Karp Capital Management Corp now owns 4,980 shares of the medical research company’s stock worth $1,451,000 after buying an additional 35 shares during the last quarter. Brandywine Oak Private Wealth LLC increased its stake in shares of Thermo Fisher Scientific by 2.0% in the third quarter. Brandywine Oak Private Wealth LLC now owns 1,813 shares of the medical research company’s stock worth $528,000 after buying an additional 36 shares during the last quarter. Landmark Bank increased its stake in shares of Thermo Fisher Scientific by 0.3% in the third quarter. Landmark Bank now owns 13,623 shares of the medical research company’s stock worth $3,968,000 after buying an additional 40 shares during the last quarter. Finally, Arvest Bank Trust Division increased its stake in Thermo Fisher Scientific by 2.8% during the third quarter. Arvest Bank Trust Division now owns 1,454 shares of the medical research company’s stock valued at $424,000 after purchasing an additional 40 shares during the last quarter. Institutional investors own 88.24% of the company’s stock.

In related news, CEO Marc N. Casper sold 2,271 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $298.00, for a total value of $676,758.00. Following the transaction, the chief executive officer now owns 283,502 shares in the company, valued at $84,483,596. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jim P. Manzi sold 1,833 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $272.93, for a total value of $500,280.69. Following the completion of the transaction, the director now owns 28,592 shares in the company, valued at approximately $7,803,614.56. The disclosure for this sale can be found here. Insiders sold 51,833 shares of company stock worth $15,299,095 in the last 90 days. 0.45% of the stock is currently owned by corporate insiders.

Several analysts have weighed in on TMO shares. JPMorgan Chase & Co. boosted their target price on shares of Thermo Fisher Scientific from $315.00 to $330.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Credit Suisse Group restated a “buy” rating and set a $310.00 price target on shares of Thermo Fisher Scientific in a research report on Wednesday, July 31st. Robert W. Baird upped their price target on shares of Thermo Fisher Scientific from $305.00 to $319.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. Barclays set a $330.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Monday, July 15th. Finally, ValuEngine lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $314.45.

TMO stock traded up $1.11 during trading on Friday, hitting $294.65. The company had a trading volume of 773,005 shares, compared to its average volume of 1,323,858. The firm has a market capitalization of $117.34 billion, a price-to-earnings ratio of 26.50, a P/E/G ratio of 1.90 and a beta of 1.14. The business has a 50 day moving average of $290.14 and a 200 day moving average of $283.57. Thermo Fisher Scientific Inc. has a fifty-two week low of $208.34 and a fifty-two week high of $306.00. The company has a current ratio of 1.80, a quick ratio of 1.23 and a debt-to-equity ratio of 0.56.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 23rd. The medical research company reported $2.94 earnings per share for the quarter, topping the consensus estimate of $2.88 by $0.06. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.16%. The business had revenue of $6.27 billion during the quarter, compared to the consensus estimate of $6.19 billion. During the same quarter in the prior year, the company posted $2.62 earnings per share. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. As a group, equities analysts predict that Thermo Fisher Scientific Inc. will post 12.33 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Tuesday, December 17th will be issued a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.26%. Thermo Fisher Scientific’s dividend payout ratio is currently 6.83%.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

See Also: Buyback For Investors Defined

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply